RESEARCHER PROFILE

Rainer R. Haas

← Back to Heinrich Heine University Düsseldorf

R

Heinrich Heine University Düsseldorf

Hematopoietic Stem Cell TransplantationAcute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processesMultiple Myeloma Research and TreatmentsMesenchymal stem cell research

Rainer R. Haas works in Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Retinoids in leukemia and cellular processes, Multiple Myeloma Research and Treatments, Mesenchymal stem cell research. Recorded institutional associations include Düsseldorf University Hospital, Heinrich Heine University Düsseldorf.

565Publications
15,158Citations
67H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma

    1994 · 470 citations
  2. Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

    2004 · 255 citations
  3. Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells

    2013 · 238 citations
  4. Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

    2013 · 225 citations
  5. The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia

    2005 · 224 citations
  6. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor.

    1990 · 217 citations
  7. Incidence and prevalence of myelodysplastic syndromes: Data from the Düsseldorf MDS-registry

    2011 · 206 citations
  8. The monoclonal anti–VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans

    2008 · 193 citations
  9. Treatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions—A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group

    2014 · 192 citations
  10. Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

    2004 · 169 citations
  11. Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)

    2005 · 162 citations
  12. Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner

    2016 · 155 citations
  13. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.

    2006 · 154 citations
  14. Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia

    2005 · 154 citations
  15. Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia

    2015 · 151 citations
  16. Thalidomide for the treatment of patients with myelodysplastic syndromes

    2002 · 150 citations
  17. Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34+ hematopoietic stem cells

    2002 · 148 citations
  18. Molecular signature of CD34+ hematopoietic stem and progenitor cells of patients with CML in chronic phase

    2007 · 148 citations
  19. Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR

    2002 · 144 citations
  20. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.

    1993 · 137 citations
  21. Tumor immune escape by the loss of homeostatic chemokine expression

    2007 · 133 citations
  22. Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody

    2001 · 133 citations
  23. Primary human CD34+ hematopoietic stem and progenitor cells express functionally active receptors of neuromediators

    2004 · 129 citations
  24. Improved survival in MDS patients receiving iron chelation therapy – A matched pair analysis of 188 patients from the Düsseldorf MDS registry

    2012 · 126 citations
  25. Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study

    2012 · 126 citations

← Return to the university profile